CIRM BBAIII execution plan.: Difference between revisions
Jump to navigation
Jump to search
m (→Year 1) |
m (→Year 1) |
||
Line 1: | Line 1: | ||
==Year 1== | ==Year 1== | ||
*iPS reprogramming. | *iPS reprogramming. | ||
**Somatic cell types: Fibroblasts (PGP1F), others?? | **Somatic cell types: Fibroblasts (PGP1F, BJ, IMR90), others?? | ||
*hESC differentiation. | *hESC differentiation. | ||
**H1 (need to obtain the cell line through MTA), Hues3, HUES8. | **H1 (need to obtain the cell line through MTA), Hues3, HUES8. |
Revision as of 16:51, 11 May 2011
Year 1
- iPS reprogramming.
- Somatic cell types: Fibroblasts (PGP1F, BJ, IMR90), others??
- hESC differentiation.
- H1 (need to obtain the cell line through MTA), Hues3, HUES8.
- Exome sequencing and mutation validation.
- Existing lines (what??) versus new lines.
- Gene knock-in/knock-down experiments.
- What genes??